Close Menu

This article has been updated with a statement from Natera.

NEW YORK (GenomeWeb) – CareDx and Stanford University today filed suit against Natera in the United States District Court for Delaware, claiming that Natera has infringed on US Patents 9,845,497 and 8,703,652, which are exclusively licensed to CareDx from Stanford University. 

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

The New York Times Magazine examines gender discrimination at the Salk Institute.

Science reports that MD Anderson Cancer Center has dismissed three researchers over foreign tie concerns.

A second death in gene therapy trial for type 1 spinal muscular atrophy is under investigation, according to Reuters.

In PLOS this week: antibiotic resistance patterns in Escherichia coli, a dozen genetic loci tied to varicose vein risk, and more.